Home > Boards > US OTC > Biotechs >

Delcath Systems Inc. (DCTH)

DCTH RSS Feed
Add DCTH Price Alert      Hide Sticky   Hide Intro
Moderator: CanadaGreece, TheGreatGuy
Search This Board: 
Last Post: 9/22/2019 5:23:34 PM - Followers: 522 - Board type: Free - Posts Today: 0

Web Site: Delcath Systems, Inc.
Stock and Financial Info: OTC Marketplace
About Delcath Systems (OTCQB:DCTH)
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Their proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In the United States, the Melphalan/HDS system is considered a combination drug and device product, and is regulated as a drug by the United States Food and Drug Administration (FDA). The Melphalan/HDS system has not been approved for sale in the United States. In Europe, their proprietary system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In April 2012, they obtained authorization to affix a CE Mark for the Generation Two CHEMOSAT system. The right to affix the CE mark allows the Company to market and sell the CHEMOSAT system in Europe. The Company has commenced a global phase 2 clinical trial in Europe to investigate Melphalan/HDS system for primary liver cancer and is initiating plans to evaluate intrahepatic cholangiocarcinoma.
 
Delcath Systems was formed in 1988 as a Pharmaceutical and Medical Device company focused on oncology. The company is registered in Delaware with offices in New York, New York and Manufacturing, Distribution, Research and Development facilities located in Queensbury, New York. The company currently has 10 patents in their US Intellectual Property portfolio according to the US Patent Office.
 
Subsidiaries of Delcath Systems include Delcath Holdings Limited (Ireland), Delcath Systems Limited (Ireland), Delcath Systems B.V. (Netherlands), Delcath Systems Gmbh (Germany) and Delcath Systems UK (United Kingdom).
 
Delcath Systems Securities
Delcath Systems securities originally came on the market on June 16, 2000 with an IPO offering of 1.2m shares priced at $6.00 per share. Securities were listed on both the NASDAQ and Boston Stock Exchange. The stock moved from the NASDAQ to the OTCQB on September 15, 2017 after the company Voluntarily Delisted it from NASDAQ and requested an Accelerated listing in the OTC marketplace.


Stock Split History
The stock has been (reverse) split a total of 4 times. Twice while on the NASDAQ and twice since moving to the OTCQB.
 
The 1st split came on April 9, 2014 at a ratio of 1:16
The 2nd split came on July 21, 2016 at a ratio of 1:16
The 3rd split came on November 6, 2017 at a ratio of 1:350
The 4th split came on May 2, 2018 at a ratio of 1:500


Delcath Share Information
Common Shares Authorized: 1,000,000,000
Preferred Shares Authorized: 
10,000,000
Common Shares Outstanding*: 17,464,807 (a/o 5/01/2019)
Preferred Shares Outstanding**: (a/o 4/02/2019) 

Fully Diluted Common Shares as of November 5, 2018 ***


* From OTC Markets on 05/01/2019 / ** From SEC Filing 04/02/1019 / *** From SEC Filing on 11/07/2018
 
Delcath Systems Clinical Trials
Declcath Systems currently has two clinical trials underway. The first is the FOCUS Trial and the second the ALIGN Trial.
 
The FOCUS Trial is designed to evaluate patients who have melanoma that has spread from the eye to the liver. All patients in the study will be treated with Melphalan/HDS for up to 6 treatments. This study will evaluate the safety and effects of the treatment on how long patients live and how long it takes for the cancer to advance or respond to the treatment. The FOCUS Trial has an estimated completion date of April 2020. For more info click here  
 
The ALIGN Trial will evaluate two groups of patients who have intrahepatic cholangiocarcinoma. Each group will receive induction treatment with Cisplatin and Gemcitabine per SOC for 4 treatment cycles. Following induction treatment patients will be randomize (1:1), to 2 arms of treatment. One group (50%) will rreceive high dose chemotherapy delivered specifically to the liver, while the other group (50%) will continue treatment with Cisplatin and Gemcitabine. Patient in each group will get repeating cycles of treatment until the cancer advances. All patients will be followed until death. This study will compare the overall survival (OS) in patients with intrahepatic cholangiocarcinoma. The ALIGN Trial has an estimated completion date of January 2023. For more info click here
DCTH
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DCTH News: Current Report Filing (8-k) 09/19/2019 05:15:53 PM
DCTH News: Small Company Offering and Sale of Securities Without Registration (d) 08/27/2019 02:54:57 PM
DCTH News: Securities Registration Statement (s-1) 08/21/2019 05:31:45 PM
DCTH News: Current Report Filing (8-k) 08/20/2019 10:33:18 AM
DCTH News: Proxy Statement (definitive) (def 14a) 08/19/2019 08:06:56 AM
PostSubject
#49380   lets forget all guys.lets have last round buying TheGreatGuy 09/22/19 05:23:34 PM
#49379   1-1,200 reverse split just approved how are these onfirestocks 09/22/19 09:11:18 AM
#49378   they just gave themselves $9 million dollars in onfirestocks 09/22/19 09:09:15 AM
#49377   Seen this before; multiple reverses over a series echi8 09/20/19 11:40:39 PM
#49376   It will take effect as soon as reasonably Filterthenoise 09/20/19 03:56:37 PM
#49375   speaking of Nasdaq promise, in the last reverse Bond 09/20/19 02:28:22 PM
#49374   GLTY.....though I am not even sure luck will help. Lwe6638 09/20/19 01:06:26 PM
#49373   SEC filings seem to detail the scam openly, SAMNOTSAMUEL 09/20/19 11:37:15 AM
#49372   Ha auto correct. Doing good. Cheers CanadaGreece 09/20/19 11:31:40 AM
#49371   If i analyse all SEC fillings of Delcath TheGreatGuy 09/20/19 11:09:32 AM
#49370   Not sure what you mean...but if you are Lwe6638 09/20/19 10:51:23 AM
#49369   Not that it is 100 percent certain at SAMNOTSAMUEL 09/20/19 10:19:35 AM
#49368   Well I'm doing going so far for a CanadaGreece 09/20/19 10:07:55 AM
#49367   This isnt going to NASDAQ. The company doesnt Lwe6638 09/20/19 09:57:32 AM
#49366   To reaching 2$ from current price.this stock should TheGreatGuy 09/20/19 09:38:17 AM
#49365   I continue to believe that is very likely, SAMNOTSAMUEL 09/20/19 08:44:37 AM
#49364   Lets start last round buy from today. TheGreatGuy 09/20/19 08:31:39 AM
#49363   So the stock price will not rise from CanadaGreece 09/20/19 06:50:05 AM
#49362   Sue this company they are nothing but thieves.... Johnstonj27 09/20/19 12:36:21 AM
#49361   One VERY important note......authorized shares will NOT be Lwe6638 09/20/19 12:02:00 AM
#49360   It will take effect as soon as reasonably Turntheship 09/19/19 11:51:33 PM
#49359   More importantly Filterthenoise 09/19/19 10:49:16 PM
#49358   Without knowledge, it is always best here to SAMNOTSAMUEL 09/19/19 09:55:52 PM
#49357   Rs 1 for 100 asap. Turntheship 09/19/19 07:45:12 PM
#49356   So the REVERSE SPLIT bug has hit DCTH. elkonig 09/19/19 07:25:56 PM
#49355   I’m in brother. I’ll continue to buy Muenster Madness 09/19/19 06:52:21 PM
#49354   Don't be so sure this drops after CanadaGreece 09/19/19 06:33:15 PM
#49353   The question that remains is how dire is Filterthenoise 09/19/19 06:00:17 PM
#49352   well well well, just another RS in delcath arena. Bond 09/19/19 05:51:45 PM
#49351   On September 17, 2019, the Company’s Board of TheGreatGuy 09/19/19 05:40:24 PM
#49350   Lol another reverse split...lol I laf insanely. Best WhatYouTalkinBout 09/19/19 05:29:37 PM
#49349   Just waiting for miracle which is dated but TheGreatGuy 09/19/19 11:05:29 AM
#49348   Might be a decent time to lighten up CanadaGreece 09/19/19 10:19:51 AM
#49347   now it is totally in danger. TheGreatGuy 09/19/19 09:47:40 AM
#49346   I will be surprised if the reverse split SAMNOTSAMUEL 09/19/19 08:45:49 AM
#49345   Keep in mind there was a 1 year Filterthenoise 09/18/19 09:01:34 PM
#49344   You currently own over 1% of the company’s Muenster Madness 09/18/19 05:05:17 PM
#49343   what meeting.hhhhhhaaaa.Have fun. everything is fixed. these are TheGreatGuy 09/18/19 04:50:13 PM
#49342   Well that was uneventful. Anyone hear of the Muenster Madness 09/18/19 04:24:19 PM
#49341   sobbing or shaving.lol TheGreatGuy 09/17/19 03:03:39 PM
#49340   You didn’t hear me gently sobbing to Jessica Muenster Madness 09/17/19 02:07:50 PM
#49339   none of the shareholders present here and gone? Andresquo 09/17/19 01:02:03 PM
#49338   lol. what is use of it. they will TheGreatGuy 09/17/19 12:57:59 PM
#49337   When will we hear an update? Filterthenoise 09/17/19 12:55:46 PM
#49336   Isn’t the call today? Muenster Madness 09/17/19 12:47:08 PM
#49335   what you are waiting for ? TheGreatGuy 09/17/19 10:11:56 AM
#49334   Let em have it tomorrow. Muenster Madness 09/16/19 04:20:22 PM
#49333   E anche sta volta... me lo prendo dietro... Andresquo 09/13/19 04:37:30 PM
#49332   GMGI still a GREAT BUY .0063 and still combackid 09/12/19 01:08:00 PM
#49331   soon they ll begin to pump.. fliegenfranz1 09/11/19 12:01:18 PM
PostSubject